Ansari B, Abbaspour MR, Estajy A, Haghnavaz N, Pordel S, Rezaee M, Shobeiri SS, Moghadam M, Hashemi M, Sankian M. Development of fast-dissolving sublingual nanofibers containing allergen and curcumin for immune response modulation in a mouse model of allergic rhinitis. Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7839-7856. doi: 10.1007/s00210-024-03139-y. Epub 2024 May 14. PMID: 38743115.
Pordel S, Haghnavaz N, Rezaee M, Shobeiri SS, Ansari B, Dashti M, Moghadam M, Khorrami M, Sankian M. An epicutaneous therapeutic pollen-allergen extract delivery system in an allergic rhinitis mouse model: based on allergen loading on DC-specific aptamers conjugated nanogolds. Immunol Res. 2024 Jun;72(3):460-475. doi: 10.1007/s12026-023-09445-6. Epub 2023 Dec 13. PMID: 38091227.
Pordel S, McCloskey AP, Almahmeed W, Sahebkar A. The protective effects of statins in traumatic brain injury. Pharmacol Rep. 2024 Apr;76(2):235-250. doi: 10.1007/s43440-024-00582-9. Epub 2024 Mar 7. PMID: 38448729.
Haghnavaz N, Rezaee MA, Pordel S, Shobeiri SS, Dashti MR, Ansari B, Khorrami M, Moghadam M, Sankian M. Mannose targeting of poly(lactic-co-glycolic acid): a promising approach for improving sublingual allergen-specific immunotherapy. Immunopharmacol Immunotoxicol. 2024 Dec;46(6):815-828. doi: 10.1080/08923973.2024.2410291. Epub 2024 Oct 8. PMID: 39376102.
Emami Z, Shobeiri SS, Khorrami R, Haghnavaz N, Rezaee MA, Moghadam M, Pordel S, Sankian M. Evaluation of Kynu, Defb2, Camp, and Penk Expression Levels as Psoriasis Marker in the Imiquimod-Induced Psoriasis Model. Mediators Inflamm. 2024 Jul 16;2024:5821996. doi: 10.1155/2024/5821996. PMID: 39045230; PMCID: PMC11265934.